ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
9,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
10,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
12,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
16,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
17,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
19,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
20,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
22,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
23,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
24,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
25,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
26,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
27,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
28,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
30,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
32,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
32,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
33,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
34,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
36,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
37,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
38,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
39,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
40,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
41,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
43,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
44,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
44,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
45,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
45,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
46,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
49,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
49,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
49,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
49,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
49,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
51,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
53,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
54,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
57,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
57,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
59,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
61,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
63,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
63,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
63,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
64,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
64,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
65,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Headache,Headaches NEC,Headaches,Nerv,N
66,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
67,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
67,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
68,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
68,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
69,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
70,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
71,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
71,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
71,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,7,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
71,8,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
72,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
72,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
73,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
74,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
74,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
74,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
75,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
75,2,Brain natriuretic peptide abnormal,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
75,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
75,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
75,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
75,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
75,7,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
76,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
78,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
79,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
79,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
80,1,Blood pressure inadequately controlled,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
81,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
81,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
82,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
83,1,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
84,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
84,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
85,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
85,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
87,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
87,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
88,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
88,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
88,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
88,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
88,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
89,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
90,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
90,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
91,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
92,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
92,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
92,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
92,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
93,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
94,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
94,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
95,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
96,1,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
96,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
96,3,Tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
97,1,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
97,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
99,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
100,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
100,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
101,1,Migraine,Migraine headaches,Headaches,Nerv,N
102,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
103,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
